Tìm kiếm
Vanda Pharmaceuticals Inc
VNDAThêm vào danh sách theo dõi
5.130USD
+0.020+0.39%
Đóng cửa 09-18 16:00（ET）
309.23MVốn hóa
LỗP/E TTM
Thêm thông tin về Vanda Pharmaceuticals Inc Công ty
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.
Vanda Pharmaceuticals Inc Hồ sơ
Mã chứng khoánVNDA
Tên công tyVanda Pharmaceuticals Inc
Ngày IPOApr 12, 2006
Giám đốc điều hànhPolymeropoulos (Mihael Hristos)
Số lượng nhân viên368
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhApr 12
Địa chỉSuite 300E
Thành phốWASHINGTON
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện20037
Điện thoại12027343400
Trang webhttps://www.vandapharma.com/
Mã chứng khoánVNDA
Ngày IPOApr 12, 2006
Giám đốc điều hànhPolymeropoulos (Mihael Hristos)
Lãnh đạo công ty của Vanda Pharmaceuticals Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
President, Chief Executive Officer and Chairman of the Board
President, Chief Executive Officer and Chairman of the Board
1.59M
-70.28%
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
President, Chief Executive Officer and Chairman of the Board
President, Chief Executive Officer and Chairman of the Board
1.59M
-70.28%
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
President, Chief Executive Officer and Chairman of the Board
President, Chief Executive Officer and Chairman of the Board
1.59M
-70.28%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
219.05K
+18.99%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
219.05K
+18.99%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
219.05K
+18.99%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
204.77K
-141.34%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
204.77K
-141.34%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
204.77K
-141.34%
Ms. Anne Sempowski Ward
Ms. Anne Sempowski Ward
Independent Director
Independent Director
160.67K
+25.89%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
President, Chief Executive Officer and Chairman of the Board
President, Chief Executive Officer and Chairman of the Board
1.59M
-70.28%
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
President, Chief Executive Officer and Chairman of the Board
President, Chief Executive Officer and Chairman of the Board
1.59M
-70.28%
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
President, Chief Executive Officer and Chairman of the Board
President, Chief Executive Officer and Chairman of the Board
1.59M
-70.28%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
219.05K
+18.99%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
219.05K
+18.99%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
219.05K
+18.99%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Vanda Pharmaceuticals Inc?
Năm cổ đông hàng đầu của Vanda Pharmaceuticals Inc là: Dr. Mihael Hristos Polymeropoulos, M.D.
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Vanda Pharmaceuticals Inc (VNDA)?
Tính đến ngày 2026Q1, có 353 tổ chức nắm giữ cổ phiếu của Vanda Pharmaceuticals Inc, với tổng giá trị thị trường khoảng 47.15M, chiếm 78.40% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -5252737.00.
Nguồn doanh thu lớn nhất của Vanda Pharmaceuticals Inc là gì?
Vào ngày 2026Q1, bộ phận kinh doanh Fanapt đã tạo ra doanh thu cao nhất cho Vanda Pharmaceuticals Inc, đạt 35.99M, chiếm 71.22% tổng doanh thu.